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1. Introduction
  Obsessive compulsive disorder (OCD) is thought to be one 
of the most intractable and disabling anxiety related mental 
disorders in the community (characterized by persistent 
and distress causing thoughts (obsessions), which are ego-
dystonic and seemingly purposeful behavior (compulsions)
[1-4]. The brain areas like orbitofrontal cortex, the anterior 
cingulated cortex, the dorsolateral prefrontal cortex are 
involved in the pathophysiology of the OCD. The defects in 
serotonergic system has been implicated in OCD[5,6]. Some 
reports also indicated the involvement of the dopaminergic 
system in OCD[7]. Although OCD is classified as an 
anxiety disorder, practical anxiolytic agents are generally 
ineffective in reducing symptoms of OCD. At present, the 
most efficacious pharmacological treatments for OCD are 
antidepressants with serotonin (5-hydroxytryptamine) 
reuptake inhibition[5].
  Withania somnifera (W. somnifera) (WS) or Ashwagandha, 
also known as “Winter Cherry” is the most famous 
Ayurvedic rejuvenative botanical (rasayana) that improves 
the body’s ability to maintain physical effort and helps 
the body adapt to various types of stress. It is especially 
beneficial in stress related disorders such as arthritis, 
hypertension, diabetes, general debility, etc. The roots of 
W. somnifera are used to promote physical and mental 
health, W. somnifera has been used to stabilize mood in 
patients with behavioral disturbances[8]. Though animal 
experimentation supported the use of W. somnifera as 
a mood stabilizer in clinical conditions of anxiety and 
depression in Ayurveda, W. somnifera is found to decrease 
the degree of anxiety and depression and can be used 
as antidepressant. The anxiolytic and antidepressant 
actions of the bioactive glycowithanolides, isolated from
W. somnifera roots, has been investigated in rats. The plants 
contain the alkaloids withanine and somniferine, which are 
used to treat nervous disorders[8].
  Those plants which are used to treat anxiety and 
depression can be potential therapeutic strategy for 
treatment of OCD. Incidentally, it is found that W. somnifera 
possesses anxiolytic and antidepressant effect. Hence, it 
is contemplated that W. somnifera may be useful in the 
treatment of obsessive-compulsive disorder. Therefore, 
it was proposed to study the influence of methanolic and 
aqueous extract of W. somnifera root was investigated on the 
marble-burying behavior of mice-a well-accepted model 
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of obsessive-compulsive behavior[9]. Further, the effect of 
W. somnifera root extracts is compared with the effect of 
fluoxetine a standard anti-OCD agent. To understand the 
involvement of serotonergic system, the effect of methanolic 
extract of W. somnifera is further studied in mice, pre-
treated with either sub-effective dose of fluoxetine, or 
parachlorophenylalanine (PCPA)–a serotonin depleting 
agent.
2. Material and methods
2.1. Plant material
  Dried root of W. somnifera were collected from the 
medicinal garden of Central Research Institute (Ay.), 
Aamkho, Gwalior, India. The identification of plant was 
done by Shri N.K. Pandey, Research Officer (Botany), Central 
Research Institute (Ay.), Aamkho, Gwalior, India. A voucher 
specimen (Field Book no. 10629) of the authenticated
W. somnifera has been deposited in the herbarium of the 
Institute. The roots were coarsely powdered and subjected 
to defatting in Soxhlet apparatus using petroleum ether (60-
80 曟). The defatted air dried root powder was subjected 
to extraction in soxhlet apparatus using methanol. 
Concentrated extract was collected from the extraction-pot 
of soxhlet apparatus (MEWS). These air dried root powder 
was subjected to simple maceration process. The material 
was macerated with chloroform and water (1:4) for 48 h at 
room temperature with occasional stirring daily. The mixture 
was filtered and the filtrate was heated (below 55 曟) and 
evaporated in rotary evaporator under reduced pressure till 
a strong brownish liquid was obtained (AEWS).
2.2. Animal
  Swiss albino mice (22-25 g) of either sex were used. They 
were housed in groups (n=6) in polypropylene cages, under 
a standard 12 h light/dark cycle and controlled conditions 
of temperature and humidity (25±2) 曟, (55±2)%. They 
received the standard rodent chow and water ad libitum. 
Drug administrations and experiments were carried between 
9:00 am to 3:00 pm in a noise free room. The animal studies 
were approved by Institutional Animal Ethics Committee 
constituted for the purpose of control and supervision of 
experiments on animals.
2.3. Drug
  Fluoxetine (Esteem Pharmaceuticals, Agra), and ritanserin 
(Sun Pharma Advanced Research Center, Vadodara, India) 
were obtained as gift samples. Parachlorophenylalanine was 
purchased from Sigma Aldrich, USA. All the above drugs 
were dissolved in 0.9% saline. Drug solutions were freshly 
prepared and their doses are expressed in terms of their free 
bases.
2.4. Doses and treatments
  Mice were divided in different groups (n=6). Fluoxetine (5, 
10, 15 mg/kg), AEWS (10, 25, 50, 100 mg/kg) and MEWS (10, 
25, 50, 100 mg/kg) were administered i.p. 30 min prior to 
the assessment of marble burying behavior and locomotor 
activity. The control group received 0.9% saline or vehicle 
of the extract. In another set of experiments, mice were 
pretreated with serotonergic neurotoxin, PCPA (300 mg/kg)
for three consecutive day and 24 h, thereafter MEWS
(50 mg/kg) or AEWS (50 mg/kg) or fluoxetine (15 mg/kg) were 
administered. After thirty minutes, the marble burying 
behavior and motor activity was assessed in separate 
groups. In another set of experiments mice were pretreated 
with fluoxetine (5 mg/kg) and after 30 min AEWS (10 mg/kg)
or MEWS (10 mg/kg) were administered. After thirty 
minutes, the marble burying behavior and motor activity 
was assessed in separate groups. In another group, 5HT2A/2C 
antagonist, ritanserin (10 mg/kg) was given 30 min prior to 
administration of MEWS (50 mg/kg), AEWS (50 mg/kg) and
30 min later the above behavioral parameters were observed. 
The doses of fluoxetine, PCPA and ritanserin were based on 
previous reports[10].
2.5. Marble-burying behaviour tests
  Marble-burying model was used for studying the marble 
burying behaviour of mice[11]. Mice were individually placed 
in separate plastic cages (21 cm×38 cm×14 cm) containing 20 
clean glass marbles (10 mm in diameter) evenly spaced on 
5 cm deep saw dust. After 30 min exposure to the marbles, 
mice were removed and results were expressed as number 
of marbles buried at least two-third in saw dust. The total 
number of marbles buried was considered as an index of 
obsessive compulsive behaviour.
2.6. Locomotor activity tests
  As OCD is influenced by motor activity, the same was 
assessed in separate groups of mice using actophotometer 
(Medicraft Electromedicals Pvt. Ltd., Lucknow) equipped 
with six infrared beams and photocells connected to the 
digital counter with rectangular arena of 30×30. Motor 
activity was assessed in terms of total number of counts of 
light beam interruption in 20 min.
2.7. Statistical analysis
  The data were analyzed by one way ANOVA followed by 
Newman-Keul’s test for multiple comparisons and two-
way ANOVA followed by Bonferroni test for multiple 
comparisons, wherever applicable. The results are expressed 
as mean±SEM. A difference of P<0.05 was considered 
significant in all cases. 
3. Result
3.1. Effect of AEWS on marble-burying behavior and motor 
activity
  One way ANOVA exhibited that AEWS significantly [F (4, 
25) = 97.14, P<0.000 1] influenced marble burying behavior. 
The post hoc test showed that AEWS (25, 50 and 100 mg/kg) 
significantly reduced the no. of marbles buried (P<0.001) 
while the lower dose of AEWS (10 mg/kg) did not significantly 
reduced no. of marbles buried (P>0.05). Motor activity was 
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not affected by AEWS (10, 25 and 50 mg/kg) [F (4, 25) = 
15.68, P>0.05]; however, AEWS (100 mg/kg) significantly 
suppressed the locomotor activity (P<0.001) and excluded 
from further study (Table 1).
3.2. Effect of MEWS on marble-burying behavior and motor 
activity
  One way ANOVA exhibited that MEWS significantly [F (4, 
25) = 78.22, P<0.000 1] influenced marble burying behavior. 
The post hoc test showed that MEWS (25, 50 and 100 mg/kg)
significantly (P<0.001) reduced the no. of marbles 
buried while the lower dose of MEWS (10 mg/kg) did not 
significantly reduced no. of marbles buried (P>0.05). Motor 
activity was not affected by MEWS (10, 25 and 50 mg/kg)
[F (4, 25) = 6.14, P>0.05]; however, MEWS (100 mg/kg) 
significantly suppressed the locomotor activity (P<0.01) and 
also excluded from further study (Table 2).
3.3. Effect of fluoxetine on marble-burying behavior and 
motor activity
  One way ANOVA indicated that fluoxetine significantly 
[F (3, 20) =66.00, P<0.000 1] influenced marble burying 
behavior. The post hoc test showed that fluoxetine (10 and
15 mg/kg) dose dependently (P<0.001) reduced marble burying 
behavior in mice without any effect on motor activity [F (3, 
20) =2.21, P>0.05] while the lower dose of fluoxetine (5 mg/kg)
was found to be ineffective (P>0.05) (Table 3).
3.4. Effect of AEWS, MEWS and fluoxetine on marble-
burying behavior and motor activity
  One way ANOVA indicated that fluoxetine and AEWS or 
MEWS on combined administration has significant [F (5, 30) 
=88.80, P<0.000 1] influence on marble burying behavior. 
The post hoc test showed that co-administration of sub-
effective dose of AEWS (50 mg/kg) with sub-effective dose of 
fluoxetine (5 mg/kg) significantly (P<0.001) attenuated marble 
burying behavior. Similarly, co-administration of sub-
effective dose of MEWS (50 mg/kg) with sub-effective dose of 
fluoxetine (5 mg/kg) significantly (P<0.001) attenuated marble 
burying behavior. AEWS or MEWS along with fluoxetine 
has no effect on motor activity [F (5, 30) = 0.309, P=0.903 3] 
(Table 4).
3.5. Effect of AEWS and MEWS on marble-burying behavior 
and motor activity in PCPA treated mice
  Two way ANOVA indicated that AEWS or MEWS and 
fluoxetine has significant interaction with PCPA and 
influenced: PCPA-drug treatment interaction [F (3, 40) = 
28.85, P<0.000 1]; PCPA treatment [F (1, 40) = 149.4, P<0.000 
1] and drug treatment interaction [F (3,40) = 89.54, P<0.000 
1] the marble burying behavior. Post hoc test suggested 
pretreatment of mice with PCPA partially but significantly 
attenuated (P<0.001) the inhibitory effect AEWS and MEWS 
and completely eliminated (P<0.001) the effect of fluoxetine 
on the burying behavior with no per se effect (P>0.05). All 
these treatments did not influence the motor activity: PCPA-
drug treatment interaction [F (3, 40) = 0.222, P=0.880 1]; PCPA 
treatment [F (1, 40) = 0.095, P=0.759] and drug treatment 
interaction [F (3, 40) = 1.526, P=0.222 5] (Table 5).
3.6. Effect of ritanserin and AEWS and MEWS on marble 
burying behavior and motor activity
  Prior treatment of animals with ritanserin (10 mg/kg) 
significantly affected the inhibitory influence of AEWS (50 
mg/kg) or MEWS (50 mg/kg) on marble burying behavior [F 
(5, 30) = 92.75, P<0.000 1]. Post hoc test showed that AEWS 
or MEWS showed reduction in inhibition of marble burying 
(P<0.001) in the presence of ritanserin and without any 
change in locomotor activity [F (5, 30) = 0.318, P=0.897 8]. 
There was no effect on no. of marbles buried when mice 
were treated with alone ritanserin (10 mg/kg) (P>0.05) (Table 
6).
Table 1
Effect of AEWS on marble burying behavior and motor activity.
Group Number of marble buried Number of locomotors count
Vehicle  12.12依0.73    495.50依15.42
AEWS 10 mg/kg  11.31依0.42  480.71依7.22
AEWS 25 mg/kg    4.22依0.56    550.42依20.12
AEWS 50 mg/kg     1.10依0.37*    540.32依22.46
AEWS 100 mg/kg     0.47依0.12*     280.24依20.46*
Results are expressed as mean 依 SEM, *P<0.001 when compared to vehicle.
Table 2
Effect of MEWS on marble burying behavior and motor activity.
Group Number of marble buried Number of locomotors count
Vehicle 12.78依0.84 499.24依20.42
MEWS 10 mg/kg 13.12依0.96 492.66依15.24
MEWS 25 mg/kg     5.28依0.76* 520.22依20.46
MEWS 50 mg/kg     0.42依0.18* 522.28依18.42
MEWS 100 mg/kg     0.24依0.10*   340.22依16.98*
Results are expressed as mean 依 SEM, *P<0.001 when compared to vehicle.
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4. Discussion 
  In pharmacological investigations, the possible influence 
of extracts of W. somnifera was studied on marble burying 
behavior in mice. Results of the investigations revealed 
AEWS and MEWS reduced the marble burying behavior 
and exhibited anti-OCD like effect. This effect of AEWS 
and MEWS was comparable to standard, anti-OCD drug, 
fluoxetine which also reduced the marble burying behavior 
in concordance with the previous findings[12]. The maximum 
effective dose of AEWS and MEWS was 50 mg/kg, at which 
there was no change in the motor activity. The dose of 100 
mg/kg also exhibited inhibitory effect on MBB, but it also 
reduced the motor activity. Hence, it is not clear whether the 
effect of AEWS or MEWS at 100 mg/kg is per se effect or it is 
due to inhibition of motor activity. The present study is the 
first to investigate the influence of W. somnifera extracts on 
marble burying behavior. This indicates that the AEWS and 
MEWS both have anti-OCD like effect. The anti-OCD like 
effect of AEWS and MEWS was further substantiated by the 
observation that the sub-effective dose of AEWS and MEWS 
potentiated the effect of sub-effective dose of fluoxetine 
and exhibited the significant marble burying behavior. 
This effect of AEWS and MEWS to potentiate the action of 
fluoxetine differentiates it from anti-anxiety to anti-OCD 
drug. 
   Although the exact mechanism of action of AEWS or 
MEWS to exhibit anti-obsessive activity was not elucidated 
in the present study, it appears the extracts act as like 
fluoxetine i.e. through serotonergic system. The involvement 
of serotonergic system was substantiated by the fact that the 
pretreatment of mice with PCPA partially but significantly 
Table 3
Effect of fluoxetine on marble burying behavior and motor activity.
Group Number of marble buried Number of locomotors count
Vehicle  12.48依0.18   500.42依20.38
Fluoxetine 5 mg/kg  10.38依0.76   496.88依16.12
Fluoxetine 10 mg/kg     3.56依1.24*   460.38依10.22
Fluoxetine 15 mg/kg     0.58依0.12* 430.12依5.41
Results are expressed as mean 依 SEM, *P<0.001 when compared to vehicle.
Table 4
Effect of AEWS, MEWS and fluoxetine on marble burying behavior and motor activity.
Group Number of marble buried Number of locomotors count
Vehicle 12.36依1.12   498.36依25.12
Fluoxetine 5 mg/kg 10.24依0.36   496.42依16.26
AEWS 10 mg/kg 11.46依0.56   490.24依10.68
MEWS 10 mg/kg 12.94依1.34 495.76依8.22
Fluoxetine 5 mg/kg + AEWS 10 mg/kg    0.00依0.00*   510.38依20.12
Fluoxetine 5 mg/kg + MEWS 10 mg/kg    0.00依0.00*   506.32依10.88
Results are expressed as mean 依 SEM, *P<0.001 when compared to vehicle.
Table 5
Effect of PCPA treatment on marble burying behavior and locomotor activity.
Group Number of marble buried Number of locomotors count
Vehicle (10 mL/kg) 12.68依1.20 499.38依10.12
Vehicle (10 mL/kg)+Fluoxetine 15 mg/kg   0.12依0.06 502.76依9.82
Vehicle (10 mL/kg)+AEWS 50 mg/kg   1.20依0.32 500.12依8.43
Vehicle (10 mL/kg)+MEWS 50 mg/kg   0.32依0.12 510.68依4.40
Vehicle (10 mL/kg)+PCPA treatment 11.12依0.78 480.24依4.36
PCPA treatment +Fluoxetine 15 mg/kg   9.46依0.88 496.92依8.45
PCPA treatment + AEWS 50 mg/kg   7.32依1.42 504.36依7.38
PCPA treatment + MEWS 50 mg/kg   7.42依1.32 506.24依8.22
Results are expressed as mean 依 SEM.
Table 6
Effect of ritanserin on marble burying behavior and locomotor activity.
Group Number of marble buried Number of locomotors count
Vehicle (10 mL/kg) 12.34依1.24   500.12依16.32
Ritanserin 10 mg/kg    1.32依0.76*   516.86依14.38
AEWS 50 mg/kg    0.78依0.32*   498.12依18.92
MEWS 50 mg/kg     5.82依1.20**   502.22依10.48
Ritanserin 10 mg/kg + AEWS 50 mg/kg     5.46依0.86** 508.78依8.32
Ritanserin 10 mg/kg + MEWS 50 mg/kg 11.32依1.42 501.12依6.46
Results are expressed as mean 依 SEM, *P<0.001 when compared to vehicle, **P<0.001 when compared to respective drug control.
Bhanu PS Kaurav et al./Asian Pacific Journal of Tropical Medicine (2012)380-384384
attenuated the inhibitory effect of AEWS and MEWS and 
completely eliminated the effect of fluoxetine on the burying 
behavior. However, it is not clear by what mechanism of 
AEWS and MEWS influences serotonergic system. Previous 
study has shown that Hypericum perforatum (H. perforatum) 
(St. John’s Wort), which is known to possess antidepressant 
and anxiolytic action[13,14] has showed putative anti-
obsessive effect and it was speculated the anti-obsessive 
effect could be related to the inhibition of 5-HT reuptake 
by H. perforatum. Hyperforin was probably the major 
serotonergic component of H. perforatum that contributed to 
effect of H. perforatum on marble burying[15]. Therefore, it 
is also possible that AEWS and MEWS might have influence 
on 5-HT reuptake. The phytochemical data on W. somnifera
revealed the presence of tryptophan (Dr.  Duke ’s 
Phytochemical and Ethnobotnical Databases), which is an 
important precursor of 5HT in the serotonergic neurons. 
The preliminary phytochemical studies on of AEWS and 
MEWS revealed the presence amino acids in the extract and 
tryptophan may be enhancing the biosynthesis of serotonin 
and facilitating the anti-obsessive effect of AEWS and 
MEWS. As 5HT2A/2C is the important postsynaptic receptor 
involved in the action of standard anti-OCD agents, it 
was also observed whether AEWS and MEWS treatment 
influences 5HT2A/2C in exhibiting anti-obsessive effect. It 
was observed that prior treatment with 5HT2A/2C antagonist, 
ritanserin attenuated the effect of AEWS and MEWS on 
marble burying behavior. This indicates the involvement of 
post synaptic 5HT2A/2C receptors in the action of AEWS and 
MEWS.  This also suggests that AEWS or MEWS show the 
action through enhanced serotonergic transmission at the 
level of post synaptic 5HT2A/2C receptors. 
  Concludingly, it is clear from the present investigations 
that root extracts of W. somnifera exhibit significant anti-
obsessive effect in marble burying behavior test in mice 
and the effect may be attributed to enhanced serotonergic 
function and facilitation of serotonergic transmission. 
  The plant may exhibit various pharmacological activities. 
The previous literature has well documented the several 
effect of W. somnifera[16,17]. It has been observed that 
steroidal lactone (steroids) is believed to be responsible 
for its various pharmacological action e.q. anxiolytics, 
antidepressant, anticonvulsant, anti-inflammatory, 
antioxidant, antitumor, immunomodulatory. Hence,
W. somnifera may exhibit very potent activity and effect in 
variety of CNS disorders. As mentioned earlier, W. somnifera 
exhibit anxiolytic and antidepressant effect and such 
plants can also have influence on obsessive-compulsive 
behavior, an anxiety related disorder. Therefore, the effect of
W. somnifera on Obsessive-compulsive behavior needs to be 
evaluated.
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